Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON27060Active, not recruiting
Randomised, double-blind trial in postoperative pain comparing Levobupivacaine PCSNB, Ropivacaine PCSNB and Bupivacaine + epinephrine PCSNB (3 arms). Primary endpoint: Pain intensity at rest at 48 hours. Started Jun 2003; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON27060.